Profile data is unavailable for this security.
About the company
Wellell Inc, formerly Apex Medical Corp, is a Taiwan-based company principally engaged in the manufacture, trading, import and export of medical and healthcare related equipment. The main products include the wound management (WM) series, respiratory therapy (RT) series, welfare equipment, as well as the electronic medical devices (EMD) series, such as four-wheel walk helpers, crutches, wheelchairs, shower devices, automatic positive airway pressure (APAP) devices, interferential stimulators, electrical muscle stimulators (EMSs) and liquid crystal display (LCD) massage devices. The Company mainly distributes products to Europe, the Americas and Asia.
- Revenue in TWD (TTM)2.39bn
- Net income in TWD138.72m
- Incorporated1990
- Employees535.00
- LocationWellell IncNo.9Min Sheng Street, Peibei LiTucheng DistrictNEW TAIPEI 236TaiwanTWN
- Phone+886 222685568
- Fax+886 222689521
- Websitehttps://www.wellell.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OK Biotech Co Ltd | 1.64bn | 68.75m | 2.05bn | 62.00 | 30.51 | 0.8094 | 11.98 | 1.25 | 0.4639 | 0.4639 | 11.32 | 17.48 | 0.4478 | 2.62 | 2.98 | -- | 2.29 | 2.73 | 2.90 | 3.60 | 27.01 | 18.75 | 5.11 | 5.56 | 1.17 | 3.92 | 0.3009 | 111.05 | 40.11 | 6.11 | 3,087.75 | -5.66 | 37.07 | -24.66 |
| Wellell Inc | 2.39bn | 138.72m | 2.32bn | 535.00 | 16.90 | 0.9545 | 9.62 | 0.9709 | 1.37 | 1.37 | 23.60 | 24.20 | 0.7533 | 2.78 | 6.25 | -- | 4.40 | 4.07 | 5.47 | 5.35 | 46.15 | 42.35 | 5.85 | 5.30 | 1.99 | -- | 0.1184 | 56.36 | -9.84 | 3.23 | -24.27 | 5.56 | 13.42 | 12.20 |
| A Plus Biotechnology Co Ltd | 825.52m | 171.54m | 2.87bn | -- | 15.36 | 2.29 | 14.48 | 3.48 | 5.40 | 5.40 | 25.93 | 36.22 | 0.6253 | 0.8183 | 6,551.74 | -- | 13.00 | 5.52 | 14.85 | 6.55 | 69.53 | 65.49 | 20.79 | 9.74 | 4.42 | -- | 0.0735 | 75.94 | 14.01 | 10.18 | 384.79 | 37.11 | 8.86 | -- |
Data as of Feb 11 2026. Currency figures normalised to Wellell Inc's reporting currency: Taiwan Dollar TWD
0.51%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Dimensional Fund Advisors LPas of 05 Feb 2026 | 461.46k | 0.46% |
| Dimensional Fund Advisors Ltd.as of 30 Nov 2025 | 49.03k | 0.05% |
| DFA Australia Ltd.as of 30 Nov 2025 | 2.13k | 0.00% |
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
